Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma
Lung squamous cell carcinoma (LUSC) is a subtype of non-small cell carcinoma, accounting for about 30% of all lung cancers. Yet, the evaluation of prognostic outcome and therapy response of patients with LUSC ...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Guangxian Mao, Dongyong Yang, Bin Liu, Yu Zhang, Sijia Ma, Shang Dai, Guoqiang Wang, Wenxiang Tang, Huafei Lu, Shangli Cai, Jialiang Zhu and Huaping Yang Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Respiratory Medicine | Skin Cancer | Squamous Cell Carcinoma